Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
Descriptor ID |
D000697
|
MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 2 | 0 | 2 |
1997 | 2 | 0 | 2 |
1998 | 7 | 0 | 7 |
1999 | 1 | 0 | 1 |
2000 | 4 | 0 | 4 |
2001 | 5 | 2 | 7 |
2002 | 3 | 1 | 4 |
2003 | 4 | 2 | 6 |
2004 | 1 | 1 | 2 |
2005 | 3 | 2 | 5 |
2006 | 3 | 7 | 10 |
2007 | 2 | 3 | 5 |
2008 | 13 | 4 | 17 |
2009 | 8 | 5 | 13 |
2010 | 9 | 3 | 12 |
2011 | 3 | 1 | 4 |
2012 | 5 | 0 | 5 |
2013 | 4 | 1 | 5 |
2014 | 8 | 2 | 10 |
2015 | 4 | 2 | 6 |
2016 | 4 | 1 | 5 |
2017 | 1 | 3 | 4 |
2018 | 0 | 1 | 1 |
2019 | 3 | 0 | 3 |
2020 | 3 | 0 | 3 |
2021 | 3 | 0 | 3 |
2022 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension. Chest. 2024 Jun; 165(6):1518-1533.
-
Stimulant Drugs and Stimulant Use Disorder. Anesthesiol Clin. 2024 Mar; 42(1):103-115.
-
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. J Child Adolesc Psychopharmacol. 2023 03; 33(2):51-58.
-
Opioid-stimulant trends in overdose toxicology by race, ethnicity, & gender: An analysis in Delaware, 2013-2019. J Ethn Subst Abuse. 2024 Jul-Sep; 23(3):471-500.
-
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2021 11; 31(9):597-609.
-
Cancer-related fatigue-pharmacological interventions: systematic review and network meta-analysis. BMJ Support Palliat Care. 2023 Sep; 13(3):274-280.
-
Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKM? and increased ?OR in the hippocampus of female mice. J Psychopharmacol. 2021 Oct; 35(10):1240-1252.
-
Questionable Conceptualizations of Nonmedical Use Can Contribute to Needless Distress-Reply. JAMA Oncol. 2021 06 01; 7(6):942-943.
-
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. J Child Adolesc Psychopharmacol. 2020 12; 30(10):580-589.
-
A central role for apathy in the effectiveness of interventions for cancer-related fatigue. Psychooncology. 2020 10; 29(10):1613-1619.